nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—MAPK3—exocrine gland—cervical cancer	0.0309	0.0603	CbGeAlD
Sulindac—PTGDR2—female reproductive system—cervical cancer	0.0259	0.0506	CbGeAlD
Sulindac—AKR1B1—epithelium—cervical cancer	0.0186	0.0362	CbGeAlD
Sulindac—AKR1B1—uterine cervix—cervical cancer	0.0184	0.0359	CbGeAlD
Sulindac—AKR1B1—decidua—cervical cancer	0.0175	0.0342	CbGeAlD
Sulindac—AKR1B1—renal system—cervical cancer	0.0172	0.0336	CbGeAlD
Sulindac—AKR1B1—endometrium—cervical cancer	0.0166	0.0324	CbGeAlD
Sulindac—AKR1B1—mammalian vulva—cervical cancer	0.0161	0.0314	CbGeAlD
Sulindac—AKR1B1—uterus—cervical cancer	0.0153	0.0299	CbGeAlD
Sulindac—PPARD—uterine cervix—cervical cancer	0.0145	0.0282	CbGeAlD
Sulindac—AKR1B1—female reproductive system—cervical cancer	0.0138	0.0269	CbGeAlD
Sulindac—PPARD—decidua—cervical cancer	0.0138	0.0269	CbGeAlD
Sulindac—MAPK3—epithelium—cervical cancer	0.0134	0.0262	CbGeAlD
Sulindac—MAPK3—uterine cervix—cervical cancer	0.0133	0.026	CbGeAlD
Sulindac—MAPK3—decidua—cervical cancer	0.0127	0.0248	CbGeAlD
Sulindac—PPARD—mammalian vulva—cervical cancer	0.0127	0.0247	CbGeAlD
Sulindac—AKR1B1—female gonad—cervical cancer	0.0125	0.0245	CbGeAlD
Sulindac—MAPK3—renal system—cervical cancer	0.0125	0.0243	CbGeAlD
Sulindac—AKR1B1—vagina—cervical cancer	0.0125	0.0243	CbGeAlD
Sulindac—MAPK3—endometrium—cervical cancer	0.0121	0.0235	CbGeAlD
Sulindac—MAPK3—mammalian vulva—cervical cancer	0.0117	0.0228	CbGeAlD
Sulindac—MAPK3—uterus—cervical cancer	0.0111	0.0217	CbGeAlD
Sulindac—PPARD—female reproductive system—cervical cancer	0.0108	0.0211	CbGeAlD
Sulindac—MAPK3—female reproductive system—cervical cancer	0.00999	0.0195	CbGeAlD
Sulindac—PPARD—female gonad—cervical cancer	0.00986	0.0192	CbGeAlD
Sulindac—PPARD—vagina—cervical cancer	0.0098	0.0191	CbGeAlD
Sulindac—MAPK3—female gonad—cervical cancer	0.00909	0.0177	CbGeAlD
Sulindac—MAPK3—vagina—cervical cancer	0.00903	0.0176	CbGeAlD
Sulindac—AKR1B1—lymph node—cervical cancer	0.00806	0.0157	CbGeAlD
Sulindac—PPARD—lymph node—cervical cancer	0.00634	0.0124	CbGeAlD
Sulindac—MAPK3—lymph node—cervical cancer	0.00584	0.0114	CbGeAlD
Sulindac—Pleural effusion—Topotecan—cervical cancer	0.00417	0.074	CcSEcCtD
Sulindac—CYP1A1—epithelium—cervical cancer	0.00416	0.00811	CbGeAlD
Sulindac—CYP1A1—uterine cervix—cervical cancer	0.00412	0.00804	CbGeAlD
Sulindac—CYP1A2—renal system—cervical cancer	0.00391	0.00763	CbGeAlD
Sulindac—CYP1A1—renal system—cervical cancer	0.00386	0.00753	CbGeAlD
Sulindac—PTGS1—epithelium—cervical cancer	0.00365	0.00713	CbGeAlD
Sulindac—PTGS1—uterine cervix—cervical cancer	0.00362	0.00707	CbGeAlD
Sulindac—CYP1A1—mammalian vulva—cervical cancer	0.00361	0.00704	CbGeAlD
Sulindac—PTGS2—epithelium—cervical cancer	0.00349	0.00681	CbGeAlD
Sulindac—PTGS2—uterine cervix—cervical cancer	0.00346	0.00675	CbGeAlD
Sulindac—CYP1A1—uterus—cervical cancer	0.00344	0.0067	CbGeAlD
Sulindac—PTGS1—renal system—cervical cancer	0.00339	0.00661	CbGeAlD
Sulindac—PTGS1—endometrium—cervical cancer	0.00328	0.00639	CbGeAlD
Sulindac—PTGS2—renal system—cervical cancer	0.00324	0.00632	CbGeAlD
Sulindac—PTGS1—mammalian vulva—cervical cancer	0.00317	0.00618	CbGeAlD
Sulindac—PTGS2—endometrium—cervical cancer	0.00313	0.00611	CbGeAlD
Sulindac—CYP1A1—female reproductive system—cervical cancer	0.00309	0.00603	CbGeAlD
Sulindac—Colitis—Topotecan—cervical cancer	0.00306	0.0544	CcSEcCtD
Sulindac—PTGS1—uterus—cervical cancer	0.00302	0.00589	CbGeAlD
Sulindac—PTGS2—uterus—cervical cancer	0.00289	0.00563	CbGeAlD
Sulindac—CYP1A1—female gonad—cervical cancer	0.00281	0.00548	CbGeAlD
Sulindac—CYP1A1—vagina—cervical cancer	0.00279	0.00545	CbGeAlD
Sulindac—ALB—lymph node—cervical cancer	0.00279	0.00543	CbGeAlD
Sulindac—PTGS1—female reproductive system—cervical cancer	0.00271	0.00529	CbGeAlD
Sulindac—PTGS2—female reproductive system—cervical cancer	0.00259	0.00506	CbGeAlD
Sulindac—PTGS1—female gonad—cervical cancer	0.00247	0.00482	CbGeAlD
Sulindac—PTGS1—vagina—cervical cancer	0.00246	0.00479	CbGeAlD
Sulindac—PTGS2—female gonad—cervical cancer	0.00236	0.00461	CbGeAlD
Sulindac—PTGS2—vagina—cervical cancer	0.00235	0.00458	CbGeAlD
Sulindac—Pancytopenia—Topotecan—cervical cancer	0.0019	0.0338	CcSEcCtD
Sulindac—Neutropenia—Topotecan—cervical cancer	0.00187	0.0332	CcSEcCtD
Sulindac—CYP1A1—lymph node—cervical cancer	0.00181	0.00353	CbGeAlD
Sulindac—Pneumonia—Topotecan—cervical cancer	0.0018	0.0319	CcSEcCtD
Sulindac—Neuropathy peripheral—Topotecan—cervical cancer	0.00175	0.0311	CcSEcCtD
Sulindac—Stomatitis—Topotecan—cervical cancer	0.00174	0.0309	CcSEcCtD
Sulindac—Sweating—Topotecan—cervical cancer	0.00171	0.0304	CcSEcCtD
Sulindac—Epistaxis—Topotecan—cervical cancer	0.00168	0.0299	CcSEcCtD
Sulindac—PTGS1—lymph node—cervical cancer	0.00159	0.0031	CbGeAlD
Sulindac—PTGS2—lymph node—cervical cancer	0.00152	0.00296	CbGeAlD
Sulindac—Chills—Topotecan—cervical cancer	0.00144	0.0255	CcSEcCtD
Sulindac—Alopecia—Topotecan—cervical cancer	0.00142	0.0251	CcSEcCtD
Sulindac—Ill-defined disorder—Topotecan—cervical cancer	0.00129	0.023	CcSEcCtD
Sulindac—Anaemia—Topotecan—cervical cancer	0.00129	0.0229	CcSEcCtD
Sulindac—Angioedema—Topotecan—cervical cancer	0.00127	0.0226	CcSEcCtD
Sulindac—Malaise—Topotecan—cervical cancer	0.00126	0.0223	CcSEcCtD
Sulindac—Leukopenia—Topotecan—cervical cancer	0.00125	0.0222	CcSEcCtD
Sulindac—Myalgia—Topotecan—cervical cancer	0.00119	0.0211	CcSEcCtD
Sulindac—Chest pain—Topotecan—cervical cancer	0.00119	0.0211	CcSEcCtD
Sulindac—Arthralgia—Topotecan—cervical cancer	0.00119	0.0211	CcSEcCtD
Sulindac—Discomfort—Topotecan—cervical cancer	0.00117	0.0208	CcSEcCtD
Sulindac—Anaphylactic shock—Topotecan—cervical cancer	0.00114	0.0202	CcSEcCtD
Sulindac—Thrombocytopenia—Topotecan—cervical cancer	0.00111	0.0198	CcSEcCtD
Sulindac—Hyperhidrosis—Topotecan—cervical cancer	0.0011	0.0195	CcSEcCtD
Sulindac—Anorexia—Topotecan—cervical cancer	0.00108	0.0193	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Topotecan—cervical cancer	0.00104	0.0184	CcSEcCtD
Sulindac—Paraesthesia—Topotecan—cervical cancer	0.00102	0.0182	CcSEcCtD
Sulindac—Dyspnoea—Topotecan—cervical cancer	0.00101	0.018	CcSEcCtD
Sulindac—Dyspepsia—Topotecan—cervical cancer	0.001	0.0178	CcSEcCtD
Sulindac—Decreased appetite—Topotecan—cervical cancer	0.000989	0.0176	CcSEcCtD
Sulindac—Fatigue—Topotecan—cervical cancer	0.000981	0.0174	CcSEcCtD
Sulindac—Constipation—Topotecan—cervical cancer	0.000973	0.0173	CcSEcCtD
Sulindac—Feeling abnormal—Topotecan—cervical cancer	0.000938	0.0167	CcSEcCtD
Sulindac—Gastrointestinal pain—Topotecan—cervical cancer	0.000931	0.0165	CcSEcCtD
Sulindac—Urticaria—Topotecan—cervical cancer	0.000904	0.0161	CcSEcCtD
Sulindac—Body temperature increased—Topotecan—cervical cancer	0.0009	0.016	CcSEcCtD
Sulindac—MAPK3—IRS-related events triggered by IGF1R—MTOR—cervical cancer	0.000887	0.00206	CbGpPWpGaD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—STAT3—cervical cancer	0.000882	0.00205	CbGpPWpGaD
Sulindac—MAPK3—TCR Signaling Pathway—CD4—cervical cancer	0.000878	0.00204	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—FGFR3—cervical cancer	0.000873	0.00203	CbGpPWpGaD
Sulindac—MAPK3—TSH signaling pathway—STAT3—cervical cancer	0.000871	0.00202	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—STAT3—cervical cancer	0.000871	0.00202	CbGpPWpGaD
Sulindac—MAPK3—IGF1R signaling cascade—MTOR—cervical cancer	0.000864	0.002	CbGpPWpGaD
Sulindac—MAPK3—Insulin receptor signalling cascade—MTOR—cervical cancer	0.000864	0.002	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—STAT3—cervical cancer	0.000861	0.002	CbGpPWpGaD
Sulindac—MAPK3—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—cervical cancer	0.000857	0.00199	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HLA-DPB1—cervical cancer	0.000846	0.00196	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—MTHFR—cervical cancer	0.000842	0.00195	CbGpPWpGaD
Sulindac—Hypersensitivity—Topotecan—cervical cancer	0.000839	0.0149	CcSEcCtD
Sulindac—MAPK3—Toll Like Receptor 4 (TLR4) Cascade—CASP8—cervical cancer	0.000838	0.00194	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.000835	0.00194	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—FGFR3—cervical cancer	0.000835	0.00194	CbGpPWpGaD
Sulindac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—cervical cancer	0.000835	0.00194	CbGpPWpGaD
Sulindac—ALB—Hemostasis—SERPIND1—cervical cancer	0.000833	0.00193	CbGpPWpGaD
Sulindac—ALB—Hemostasis—GP6—cervical cancer	0.000833	0.00193	CbGpPWpGaD
Sulindac—PTGS2—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000827	0.00192	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—cervical cancer	0.000824	0.00191	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—FGFR3—cervical cancer	0.000822	0.00191	CbGpPWpGaD
Sulindac—Asthenia—Topotecan—cervical cancer	0.000817	0.0145	CcSEcCtD
Sulindac—Pruritus—Topotecan—cervical cancer	0.000805	0.0143	CcSEcCtD
Sulindac—PTGDR2—Signaling Pathways—WNT5A—cervical cancer	0.000802	0.00186	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—CASP3—cervical cancer	0.000802	0.00186	CbGpPWpGaD
Sulindac—MAPK3—TNF alpha Signaling Pathway—CASP3—cervical cancer	0.000795	0.00184	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—CASP3—cervical cancer	0.000795	0.00184	CbGpPWpGaD
Sulindac—MAPK3—AGE/RAGE pathway—EGFR—cervical cancer	0.000792	0.00184	CbGpPWpGaD
Sulindac—MAPK3—Leptin signaling pathway—STAT3—cervical cancer	0.000786	0.00182	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—FGFR3—cervical cancer	0.000785	0.00182	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—EGFR—cervical cancer	0.000782	0.00181	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—FGFR3—cervical cancer	0.000781	0.00181	CbGpPWpGaD
Sulindac—Diarrhoea—Topotecan—cervical cancer	0.000779	0.0138	CcSEcCtD
Sulindac—MAPK3—ErbB1 downstream signaling—MTOR—cervical cancer	0.000777	0.0018	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—FGFR3—cervical cancer	0.000777	0.0018	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—FGFR3—cervical cancer	0.000773	0.00179	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Telomerase—EGFR—cervical cancer	0.000773	0.00179	CbGpPWpGaD
Sulindac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—cervical cancer	0.00077	0.00179	CbGpPWpGaD
Sulindac—MAPK3—Corticotropin-releasing hormone—CTNNB1—cervical cancer	0.000766	0.00178	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—MTOR—cervical cancer	0.000766	0.00178	CbGpPWpGaD
Sulindac—MAPK3—Regulation of toll-like receptor signaling pathway—CASP8—cervical cancer	0.000755	0.00175	CbGpPWpGaD
Sulindac—Dizziness—Topotecan—cervical cancer	0.000753	0.0134	CcSEcCtD
Sulindac—AKR1B1—Metabolism—MTHFR—cervical cancer	0.000752	0.00175	CbGpPWpGaD
Sulindac—MAPK3—Toll-Like Receptors Cascades—CASP8—cervical cancer	0.000746	0.00173	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—RARB—cervical cancer	0.000734	0.0017	CbGpPWpGaD
Sulindac—ALB—Hemostasis—GP5—cervical cancer	0.000728	0.00169	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—FGFR3—cervical cancer	0.000728	0.00169	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—FGFR3—cervical cancer	0.000728	0.00169	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—FGFR3—cervical cancer	0.000728	0.00169	CbGpPWpGaD
Sulindac—Vomiting—Topotecan—cervical cancer	0.000724	0.0129	CcSEcCtD
Sulindac—MAPK3—Signaling by VEGF—MTOR—cervical cancer	0.000723	0.00168	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—FGFR3—cervical cancer	0.000721	0.00167	CbGpPWpGaD
Sulindac—MAPK3—MicroRNAs in cardiomyocyte hypertrophy—STAT3—cervical cancer	0.000718	0.00167	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Insulin receptor—MTOR—cervical cancer	0.000718	0.00167	CbGpPWpGaD
Sulindac—Rash—Topotecan—cervical cancer	0.000718	0.0127	CcSEcCtD
Sulindac—Dermatitis—Topotecan—cervical cancer	0.000717	0.0127	CcSEcCtD
Sulindac—MAPK3—Signaling by EGFR in Cancer—FGFR3—cervical cancer	0.000715	0.00166	CbGpPWpGaD
Sulindac—Headache—Topotecan—cervical cancer	0.000713	0.0127	CcSEcCtD
Sulindac—MAPK3—Signaling by PDGF—FGFR3—cervical cancer	0.000712	0.00165	CbGpPWpGaD
Sulindac—MAPK3—VEGFA-VEGFR2 Pathway—CTNNB1—cervical cancer	0.000679	0.00158	CbGpPWpGaD
Sulindac—Nausea—Topotecan—cervical cancer	0.000676	0.012	CcSEcCtD
Sulindac—MAPK3—Oncostatin M Signaling Pathway—TP53—cervical cancer	0.000673	0.00156	CbGpPWpGaD
Sulindac—PPARD—Metabolism—CA9—cervical cancer	0.000672	0.00156	CbGpPWpGaD
Sulindac—ALB—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000669	0.00155	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—EGFR—cervical cancer	0.000665	0.00154	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—HLA-DQB1—cervical cancer	0.00066	0.00153	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TAAR6—cervical cancer	0.000658	0.00153	CbGpPWpGaD
Sulindac—MAPK3—Rac1/Pak1/p38/MMP-2 pathway—TP53—cervical cancer	0.000657	0.00152	CbGpPWpGaD
Sulindac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—cervical cancer	0.000657	0.00152	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—CASP3—cervical cancer	0.000651	0.00151	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—CASP8—cervical cancer	0.000649	0.00151	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—FGFR3—cervical cancer	0.000644	0.0015	CbGpPWpGaD
Sulindac—MAPK3—Signaling by VEGF—CTNNB1—cervical cancer	0.000641	0.00149	CbGpPWpGaD
Sulindac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000628	0.00146	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—NOTCH1—cervical cancer	0.000625	0.00145	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—MTOR—cervical cancer	0.000614	0.00142	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—MTOR—cervical cancer	0.000604	0.0014	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—STAT3—cervical cancer	0.000601	0.00139	CbGpPWpGaD
Sulindac—MAPK3—Senescence-Associated Secretory Phenotype (SASP)—STAT3—cervical cancer	0.000601	0.00139	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—MTOR—cervical cancer	0.000588	0.00136	CbGpPWpGaD
Sulindac—MAPK3—Signaling by Interleukins—STAT3—cervical cancer	0.000587	0.00136	CbGpPWpGaD
Sulindac—MAPK3—L1CAM interactions—EGFR—cervical cancer	0.000587	0.00136	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000585	0.00136	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—MTOR—cervical cancer	0.000578	0.00134	CbGpPWpGaD
Sulindac—MAPK3—Alzheimers Disease—TP53—cervical cancer	0.000576	0.00134	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NOTCH2—cervical cancer	0.000563	0.00131	CbGpPWpGaD
Sulindac—MAPK3—Glucocorticoid receptor regulatory network—TP53—cervical cancer	0.000559	0.0013	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways in Glioblastoma—TP53—cervical cancer	0.000559	0.0013	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000558	0.00129	CbGpPWpGaD
Sulindac—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000558	0.00129	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—CASP3—cervical cancer	0.000555	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Insulin Signaling—MTOR—cervical cancer	0.000555	0.00129	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—MTOR—cervical cancer	0.000552	0.00128	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—CD4—cervical cancer	0.000552	0.00128	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—MTOR—cervical cancer	0.000549	0.00127	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—MTOR—cervical cancer	0.000547	0.00127	CbGpPWpGaD
Sulindac—MAPK3—ErbB1 downstream signaling—EGFR—cervical cancer	0.000546	0.00127	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—MTOR—cervical cancer	0.000544	0.00126	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—CTNNB1—cervical cancer	0.000535	0.00124	CbGpPWpGaD
Sulindac—MAPK3—PDGFR-beta signaling pathway—STAT3—cervical cancer	0.000523	0.00121	CbGpPWpGaD
Sulindac—MAPK3—Apoptosis Modulation and Signaling—TP53—cervical cancer	0.000514	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—WNT2—cervical cancer	0.000514	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—MTOR—cervical cancer	0.000512	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—MTOR—cervical cancer	0.000512	0.00119	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—MTOR—cervical cancer	0.000512	0.00119	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—MTOR—cervical cancer	0.000507	0.00118	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—MTOR—cervical cancer	0.000503	0.00117	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—MTOR—cervical cancer	0.000501	0.00116	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—EGFR—cervical cancer	0.000497	0.00115	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—FGFR3—cervical cancer	0.000496	0.00115	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—CASP3—cervical cancer	0.000491	0.00114	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—NOTCH2—cervical cancer	0.000486	0.00113	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—STAT3—cervical cancer	0.000475	0.0011	CbGpPWpGaD
Sulindac—MAPK3—BDNF signaling pathway—STAT3—cervical cancer	0.000467	0.00108	CbGpPWpGaD
Sulindac—MAPK3—Immune System—UBE3A—cervical cancer	0.000463	0.00107	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—HES1—cervical cancer	0.000461	0.00107	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—MTOR—cervical cancer	0.000453	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—AKAP13—cervical cancer	0.000451	0.00105	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000443	0.00103	CbGpPWpGaD
Sulindac—MAPK3—Disease—WNT2—cervical cancer	0.000434	0.00101	CbGpPWpGaD
Sulindac—MAPK3—Signaling by SCF-KIT—EGFR—cervical cancer	0.000431	0.001	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000427	0.000991	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—STAT3—cervical cancer	0.000427	0.00099	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—cervical cancer	0.000418	0.000969	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—cervical cancer	0.000415	0.000962	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—EGFR—cervical cancer	0.000413	0.000957	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000413	0.000957	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—EGFR—cervical cancer	0.000406	0.000942	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TERT—cervical cancer	0.000404	0.000938	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—HES1—cervical cancer	0.000398	0.000924	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—STAT3—cervical cancer	0.000396	0.000918	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—WNT5A—cervical cancer	0.000389	0.000904	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TAAR6—cervical cancer	0.000389	0.000902	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—EGFR—cervical cancer	0.000388	0.0009	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—CASP3—cervical cancer	0.000387	0.000899	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—STAT3—cervical cancer	0.000387	0.000898	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—EGFR—cervical cancer	0.000386	0.000895	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—EGFR—cervical cancer	0.000384	0.000891	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—EGFR—cervical cancer	0.000382	0.000887	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—STAT3—cervical cancer	0.00038	0.000882	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—RARB—cervical cancer	0.000375	0.00087	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—EGFR—cervical cancer	0.000375	0.00087	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—MTOR—cervical cancer	0.000372	0.000863	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—FGFR3—cervical cancer	0.000371	0.000861	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—EGFR—cervical cancer	0.00036	0.000834	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—EGFR—cervical cancer	0.00036	0.000834	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	0.00036	0.000834	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—EGFR—cervical cancer	0.000356	0.000827	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.000356	0.000825	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.000356	0.000825	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—EGFR—cervical cancer	0.000353	0.000819	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—EGFR—cervical cancer	0.000352	0.000816	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—STAT3—cervical cancer	0.00035	0.000813	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—MTOR—cervical cancer	0.000349	0.000809	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—NOTCH1—cervical cancer	0.000348	0.000808	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000348	0.000808	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000338	0.000785	CbGpPWpGaD
Sulindac—MAPK3—Disease—WNT5A—cervical cancer	0.000329	0.000762	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TERT—cervical cancer	0.000323	0.000749	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—CASP3—cervical cancer	0.000321	0.000744	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—cervical cancer	0.00032	0.000742	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—EGFR—cervical cancer	0.000318	0.000739	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—cervical cancer	0.000315	0.00073	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—EGFR—cervical cancer	0.00031	0.00072	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000308	0.000714	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—WNT2—cervical cancer	0.000304	0.000704	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—NOTCH1—cervical cancer	0.000301	0.000699	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—NOTCH1—cervical cancer	0.000301	0.000697	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—EGFR—cervical cancer	0.000296	0.000686	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—cervical cancer	0.00029	0.000673	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—STAT3—cervical cancer	0.000287	0.000667	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000284	0.000659	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—FGFR3—cervical cancer	0.000283	0.000656	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DPB1—cervical cancer	0.000276	0.000641	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.000274	0.000636	CbGpPWpGaD
Sulindac—PPARD—Metabolism—MTHFR—cervical cancer	0.000272	0.000632	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—STAT3—cervical cancer	0.000269	0.000625	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—AKAP13—cervical cancer	0.000267	0.000618	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000263	0.000611	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MTOR—cervical cancer	0.000261	0.000606	CbGpPWpGaD
Sulindac—PTGS2—Disease—WNT2—cervical cancer	0.000258	0.000598	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CA9—cervical cancer	0.000257	0.000596	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000254	0.000589	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NOTCH2—cervical cancer	0.000248	0.000576	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—cervical cancer	0.000248	0.000576	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—EGFR—cervical cancer	0.000245	0.000568	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CASP8—cervical cancer	0.000242	0.000561	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CASP3—cervical cancer	0.00024	0.000557	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CTNNB1—cervical cancer	0.000231	0.000537	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—WNT5A—cervical cancer	0.00023	0.000534	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—EGFR—cervical cancer	0.000222	0.000514	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—cervical cancer	0.000219	0.000509	CbGpPWpGaD
Sulindac—MAPK3—Immune System—HLA-DQB1—cervical cancer	0.000216	0.0005	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CA9—cervical cancer	0.000204	0.000473	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—STAT3—cervical cancer	0.000202	0.000468	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD8A—cervical cancer	0.000201	0.000467	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000201	0.000467	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—CTNNB1—cervical cancer	0.0002	0.000463	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—MTOR—cervical cancer	0.000199	0.000461	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CD4—cervical cancer	0.000199	0.000461	CbGpPWpGaD
Sulindac—PTGS2—Disease—WNT5A—cervical cancer	0.000195	0.000453	CbGpPWpGaD
Sulindac—MAPK3—Disease—HES1—cervical cancer	0.000189	0.000439	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EGFR—cervical cancer	0.000183	0.000425	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CA9—cervical cancer	0.000181	0.00042	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CTNNB1—cervical cancer	0.000176	0.000409	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—STAT3—cervical cancer	0.000174	0.000404	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000169	0.000392	CbGpPWpGaD
Sulindac—MAPK3—Disease—MTHFR—cervical cancer	0.000166	0.000385	CbGpPWpGaD
Sulindac—MAPK3—Disease—TERT—cervical cancer	0.000166	0.000384	CbGpPWpGaD
Sulindac—ALB—Metabolism—CA9—cervical cancer	0.000165	0.000383	CbGpPWpGaD
Sulindac—MAPK3—Immune System—FGFR3—cervical cancer	0.000165	0.000382	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOTCH2—cervical cancer	0.000161	0.000375	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—EGFR—cervical cancer	0.000158	0.000367	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—cervical cancer	0.000154	0.000357	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NOTCH1—cervical cancer	0.000154	0.000357	CbGpPWpGaD
Sulindac—MAPK3—Disease—FGFR3—cervical cancer	0.000152	0.000353	CbGpPWpGaD
Sulindac—MAPK3—Disease—NOTCH1—cervical cancer	0.000143	0.000331	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CASP8—cervical cancer	0.000141	0.000327	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EGFR—cervical cancer	0.00014	0.000324	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HES1—cervical cancer	0.000132	0.000307	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—cervical cancer	0.00013	0.000302	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—cervical cancer	0.000123	0.000285	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TERT—cervical cancer	0.000116	0.000269	CbGpPWpGaD
Sulindac—MAPK3—Immune System—MTOR—cervical cancer	0.000116	0.000269	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CD4—cervical cancer	0.000116	0.000268	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CA9—cervical cancer	0.000115	0.000268	CbGpPWpGaD
Sulindac—PTGS2—Disease—HES1—cervical cancer	0.000112	0.000261	CbGpPWpGaD
Sulindac—MAPK3—Disease—MTOR—cervical cancer	0.000107	0.000248	CbGpPWpGaD
Sulindac—MAPK3—Disease—CD4—cervical cancer	0.000107	0.000248	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—FGFR3—cervical cancer	0.000106	0.000247	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—MTHFR—cervical cancer	0.000104	0.000242	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTNNB1—cervical cancer	0.000103	0.000238	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOTCH1—cervical cancer	0.0001	0.000232	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTHFR—cervical cancer	9.88e-05	0.000229	CbGpPWpGaD
Sulindac—PTGS2—Disease—TERT—cervical cancer	9.85e-05	0.000229	CbGpPWpGaD
Sulindac—MAPK3—Disease—CTNNB1—cervical cancer	9.48e-05	0.00022	CbGpPWpGaD
Sulindac—PTGS2—Disease—FGFR3—cervical cancer	9.04e-05	0.00021	CbGpPWpGaD
Sulindac—MAPK3—Immune System—STAT3—cervical cancer	8.95e-05	0.000208	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EGFR—cervical cancer	8.91e-05	0.000207	CbGpPWpGaD
Sulindac—PTGS2—Disease—NOTCH1—cervical cancer	8.49e-05	0.000197	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—MTHFR—cervical cancer	8.27e-05	0.000192	CbGpPWpGaD
Sulindac—MAPK3—Disease—STAT3—cervical cancer	8.27e-05	0.000192	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EGFR—cervical cancer	8.14e-05	0.000189	CbGpPWpGaD
Sulindac—MAPK3—Disease—EGFR—cervical cancer	7.51e-05	0.000174	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MTOR—cervical cancer	7.49e-05	0.000174	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—MTHFR—cervical cancer	7.34e-05	0.00017	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CASP3—cervical cancer	6.89e-05	0.00016	CbGpPWpGaD
Sulindac—ALB—Metabolism—MTHFR—cervical cancer	6.69e-05	0.000155	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CTNNB1—cervical cancer	6.64e-05	0.000154	CbGpPWpGaD
Sulindac—PTGS2—Disease—MTOR—cervical cancer	6.36e-05	0.000148	CbGpPWpGaD
Sulindac—PTGS2—Disease—CD4—cervical cancer	6.35e-05	0.000147	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—cervical cancer	6.27e-05	0.000145	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STAT3—cervical cancer	5.79e-05	0.000134	CbGpPWpGaD
Sulindac—PTGS2—Disease—CTNNB1—cervical cancer	5.64e-05	0.000131	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EGFR—cervical cancer	5.26e-05	0.000122	CbGpPWpGaD
Sulindac—PTGS2—Disease—STAT3—cervical cancer	4.92e-05	0.000114	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—MTHFR—cervical cancer	4.68e-05	0.000109	CbGpPWpGaD
Sulindac—PTGS2—Disease—EGFR—cervical cancer	4.47e-05	0.000104	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—cervical cancer	4.42e-05	0.000102	CbGpPWpGaD
